Otsuka Holdings is a diversified Japanese healthcare group with major businesses in pharmaceuticals, nutraceuticals, and consumer products. The company is best known internationally for its psychiatric and neurological medicines, as well as for the Pocari Sweat sports drink brand, which has achieved significant market penetration across Asia.

For international investors, Otsuka Holdings presents a distinctive combination of branded pharmaceuticals and consumer health products, providing a degree of earnings diversification uncommon among pure-play pharmaceutical companies. The group's psychiatric medicine portfolio, including treatments for schizophrenia and bipolar disorder, generates revenues across major global markets, while its consumer nutraceutical and beverage businesses contribute stable cash flows primarily across the Asia-Pacific region.